REHOVOT, Israel, May 10, 2022 /PRNewswire/ — Sequentify, a Weizmann Institute of Science spinoff, enables fast and focused DNA sequencing. It combines tools from the synthetic biology and AI software fields to enable rapid targeted DNA sequencing. Sequentify exits stealth mode with $7M in raised funds led by Israel’s most active venture firm, OurCrowd. The funds will be used to accelerate R&D, delivery, and go-to-market plans for the company.

Read more here.